Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Georgia

Georgia

The Other Vaccines market in Georgia is forecasted to achieve a revenue of US$5.65m in 2024.
It is expected to exhibit a compound annual growth rate (CAGR 2024-2028) of 9.83%, leading to a market volume of US$8.22m by 2028.
When compared globally, United States is projected to generate the highest revenue of US$23,850.00m in 2024.
The demand for other vaccines in Georgia has significantly increased due to the government's efforts to enhance public health and prevent the spread of infectious diseases.

Key regions: United Kingdom, China, Europe, India, France

Market

Region

Region comparison

Currency

Analyst Opinion

The Other Vaccines market in Georgia has seen significant growth in recent years.

Customer preferences: Customers in Georgia have shown a growing interest in preventative healthcare, including vaccinations. This is partly due to increased awareness and education about the importance of vaccination, as well as the availability of vaccines through both public and private healthcare providers.

Trends in the market: One of the key trends in the Other Vaccines market in Georgia is the increasing demand for travel vaccines. As more Georgians travel abroad for business and leisure, there has been a corresponding increase in demand for vaccines that protect against diseases such as yellow fever, typhoid, and hepatitis A and B.Another trend in the market is the growing popularity of vaccines for adults. While vaccines have traditionally been associated with children, there is now a greater recognition of the importance of adult vaccination in preventing the spread of disease and protecting public health.

Local special circumstances: Georgia has a relatively high incidence of certain infectious diseases, such as hepatitis C and tuberculosis. This has led to a greater emphasis on vaccination as a preventative measure, particularly among high-risk populations such as healthcare workers and people living with HIV.

Underlying macroeconomic factors: Georgia's economy has been growing steadily in recent years, with a focus on developing its healthcare infrastructure and improving access to healthcare services. This has created a favorable environment for the Other Vaccines market, as more Georgians are able to access and afford preventative healthcare services. Additionally, Georgia's strategic location at the crossroads of Europe and Asia has made it an increasingly popular destination for business and tourism, driving demand for travel vaccines.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.